Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2013 Sep;4(9):3740-3747.
doi: 10.1039/C3SC50858G.

Functional, metal-based crosslinkers for α-helix induction in short peptides

Affiliations

Functional, metal-based crosslinkers for α-helix induction in short peptides

Sarah J Smith et al. Chem Sci. 2013 Sep.

Abstract

Many protein-protein interactions that play a central role in cellular processes involve α-helical domains. Consequently, there has been great interest in developing strategies for stabilizing short peptides in α-helical conformations toward the inhibition and interrogation of protein-protein interactions. Here, we show that tridentate Hybrid Coordination Motifs (HCMs), which consist of a natural (histidine, His) and an unnatural (8-hydroxyquinoline, Quin) metal binding functionality, can bind divalent metal ions with high affinity and thereby induce/stabilize an α-helical configuration in short peptide sequences. The Quin functionality is readily introduced onto peptide platforms both during or after solid-state peptide synthesis, demonstrating the preparative versatility of HCMs. A systematic study involving a series of HCM-bearing peptides has revealed the critical importance of the length of the linkage between the Quin moiety and the peptide backbone as well as the metal coordination geometry in determining the extent of α-helix induction. Through ZnII coordination or modification with ReI(Quin)(CO)3, the HCM-bearing peptides can be rendered luminescent in the visible region, thus showing that HCMs can be exploited to simultaneously introduce structure and functionality into short peptides.

PubMed Disclaimer

Figures

Figure 1
Figure 1
(a) Proposed scheme for α-helix induction through tridentate metal coordination by an HCM. The remaining coordination sites on the metal are likely filled by aquo ligands. (b) Chemical structures of various Quin functionalities. (c) Sequences of peptide constructs prepared in this study. The coloring scheme corresponds to that in (a).
Figure 2
Figure 2
Changes in the circular dichroism spectra of HCM-bearing peptides upon binding CuII and ZnII. Spectra were acquired at 4 °C with 10 μM peptide and 30 μM EDTA or metal in 5 mM sodium borate buffer at pH 7.5. Corresponding spectra for CoII and NiII are shown in Figure S9 and S10.
Figure 3
Figure 3
(a) H-EMeQuin fluorescence upon metal addition (λexc = 385 nm). (b) Normalized fluorescence intensity (F/F0) of each peptide when bound to ZnII as compared to the metal-free peptide.
Figure 4
Figure 4
(a) Proposed scheme for the formation of the Re(Quin)(CO)3(His) HCM upon heating and the subsequent formation of the α-helix upon cooling. (b) Observed changes in the CD spectrum upon the heating and subsequent cooling of the Re-HCM peptide. (c) Changes in the CD signal (222 nm) during heating and cooling. (d) The emission spectrum of the Re-HCM peptide obtained after the heating/cooling cycle (λexc = 410 nm). (e) The IR spectrum of the Re-HCM peptide. The peptide sample was first lyophilized and then combined with KBr to make a pellet.
Figure 5
Figure 5
Sequences of wild-type and HCM-modified Bax BH3 domain peptides (top). Far-UV CD spectra of the Bax-HCM in the presence and absence of CuII (blue) and ZnII (magenta) acquired at 4 °C (solid lines) or 25 °C (dashed lines). The samples contained 10 μM peptide and 30 μM EDTA or metal ion in a 5 mM sodium borate buffer solution at pH 7.5.

Similar articles

Cited by

References

    1. Bullock BN, Jochim AL, Arora PS. J. Am. Chem. Soc. 2011;133:14220. - PMC - PubMed
    1. Orner BP, Ernst JT, Hamilton AD. J. Am. Chem. Soc. 2001;123:5382. - PubMed
    2. Seebach D, Matthews JL. Chem. Commun. 1997:2015. 0.
    3. Gellman SH. Acc. Chem. Res. 1998;31:173.
    4. Cheng RP, DeGrado WF. J. Am. Chem. Soc. 2001;123:5162. - PubMed
    5. Kritzer JA, Lear JD, Hodsdon ME, Schepartz A. J. Am. Chem. Soc. 2004;126:9468. - PubMed
    6. Fowler SA, Blackwell HE. Org. Biomol. Chem. 2009;7:1508. - PMC - PubMed
    7. Appella DH, Christianson LA, Klein DA, Powell DR, Huang X, Barchi JJ, Gellman SH. Nature. 1997;387:381. - PubMed
    1. Chin JW, Schepartz A. J. Am. Chem. Soc. 2001;123:2929. - PMC - PubMed
    2. Zondlo NJ, Schepartz A. J. Am. Chem. Soc. 1999;121:6938.
    1. Azzarito V, Long K, Murphy NS, Wilson AJ. Nat. Chem. 2013;5:161. - PubMed
    2. Estieu-Gionnet K, Guichard G. Expert Opin. Drug Del. 2011;6:937. - PubMed
    1. Sato AK, Viswanathan M, Kent RB, Wood CR. Curr. Opin. Biotechnol. 2006;17:638. - PubMed

LinkOut - more resources